Gueudin Marie, Simon François
Unité de Virologie, GRAM EA 2636, CHU Charles Nicolle, Rouen, France.
Methods Mol Biol. 2005;304:221-8. doi: 10.1385/1-59259-907-9:221.
HIV-1 group O strains are highly divergent, and are found mainly in central Africa. The clinical course of group O infection is identical to that of HIV-1 group M infection, with rapid onset of immunodeficiency. The important divergence of the HIV-1 group O strains lead to high limitations of the commercial tests. We describe here a method based on real-time polymerase chain reaction (PCR) to quantify plasma HIV-1 group O RNA. Primers amplify both HIV-1 group O and HIV-1 group M strains. Conversely, the probe is HIV-1 group O-specific. The standard used to quantify the clinical samples is an RNA solution resulting from the transcription of a plasmid including the amplified fragment of PCR. Our technique is capable of amplifying a wide range of HIV-1 group O strains belonging to the three current clades. This technique can be used to monitor HIV-1 group O viral load, which has previously been difficult.
HIV-1 O组毒株差异极大,主要在中非被发现。O组感染的临床病程与HIV-1 M组感染相同,免疫缺陷发病迅速。HIV-1 O组毒株的重要差异导致商业检测存在很大局限性。我们在此描述一种基于实时聚合酶链反应(PCR)的方法来定量血浆中HIV-1 O组RNA。引物可扩增HIV-1 O组和HIV-1 M组毒株。相反,探针是HIV-1 O组特异性的。用于定量临床样本的标准是一种RNA溶液,它由包含PCR扩增片段的质粒转录产生。我们的技术能够扩增属于当前三个进化枝的多种HIV-1 O组毒株。该技术可用于监测此前一直颇具难度的HIV-1 O组病毒载量。